SELE
Selectin E
RP1-117P20.2; CD62E; ELAM; ELAM1; ESEL; LECAM2; CD62 antigen-like family member E; E-selectin; ELAM-1; endothelial adhesion molecule 1; endothelial leukocyte adhesion molecule 1; leukocyte endothelial cell adhesion molecule 2; leukocyte-endothelial cell adhesion molecule 2;
SELL
selectin, lymphocyte
CD62 antigen like family member L; CD62L; CD62L antigen; gp90 MEL; hLHRc; LAM 1; LAM1; LECAM1; Leu 8; LEU8; Leukocyte adhesion molecule 1; Leukocyte endothelial cell adhesion molecule 1; Leukocyte surface antigen Leu 8; LNHR; LSEL; Lyam 1; LYAM1; Lymph node homing receptor; lymphocyte adhesion molecule 1; pln homing receptor; PLNHR; selectin L; SELL; TQ1; L-selectin;
SELP
selectin P (granule membrane protein 140kDa, antigen CD62)
SELP; selectin P (granule membrane protein 140kDa, antigen CD62); GRMP, selectin P (granule membrane protein 140kD, antigen CD62); P-selectin; CD62; CD62P; GMP140; PADGEM; PSEL; GMP-140; granule membrane protein 140; granulocyte membrane protein; CD62 antigen-like family member P; platelet alpha-granule membrane protein; leukocyte-endothelial cell adhesion molecule 3; platelet activation dependent granule-external membrane protein; GRMP; LECAM3; FLJ45155;
Selplg
selectin P ligand
SELPLG; selectin P ligand; CLA; CD162; PSGL1; PSGL-1; P-selectin glycoprotein ligand 1; cutaneous lymphocyte-associated associated antigen;
SEPSECS
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
SEPSECS;Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase;
SEPX1
Selenoprotein X, 1
SEPX1; selenoprotein X, 1; SELR; SELX; MSRB1; HSPC270; methionine-R-sulfoxide reductase B1; selenoprotein R; methionine sulfoxide reductase; EC 1.8.4.-;
SELM
selenoprotein M
SELM; selenoprotein M; SelM protein; SEPM; OTTHUMP00000199395; OTTHUMP00000199396; selenoprotein SelM;
SEPHS1
selenophosphate synthetase 1
SEPHS1; selenophosphate synthetase 1; selenide, water dikinase 1; SPS; SPS1; selenium donor protein 1; selenophosphate synthase 1; selenophosphate synthetase 1 +E9; selenophosphate synthetase 1 +E9a; selenophosphate synthetase 1 major; selenophosphate syn;
SEPHS2
selenophosphate synthetase 2
SEPHS2; selenophosphate synthetase 2; selenide, water dikinase 2; SPS2; selenium donor protein 2; selenophosphate synthase 2;
SMUG1
single-strand-selective monofunctional uracil-DNA glycosylase 1
SMUG1; single-strand-selective monofunctional uracil-DNA glycosylase 1; single-strand selective monofunctional uracil DNA glycosylase; FDG; HMUDG; UNG3; MGC104370; Single strand selective monofunctional uracil DNA glycosylase 1; Single strand selective monofunctional uracil DNA glycosylase; SMUG 1; SMUG1 protein; SMUG1_HUMAN; UNG 3;
Tox
thymocyte selection-associated high mobility group box
TOX; thymocyte selection-associated high mobility group box; thymocyte selection-associated high mobility group box protein TOX; KIAA0808; TOX1; Thymus high mobility group box protein TOX; TOX 1;
EEFSEC
eukaryotic elongation factor, selenocysteine-tRNA-specific
EEFSEC; eukaryotic elongation factor, selenocysteine-tRNA-specific; selenocysteine-specific elongation factor; EFSEC; elongation factor for selenoprotein translation; SELB; elongation factor sec;
SEPN1
selenoprotein N, 1
SEPN1; selenoprotein N, 1; MDRS1, rigid spine muscular dystrophy 1 , RSMD1; selenoprotein N; RSS; selN; SELN_HUMAN; MDRS1; RSMD1;
SELS
selenoprotein S
SELS; selenoprotein S; VCP-interacting membrane protein; VIMP; ADO15; SBBI8; SEPS1; AD-015;
THEMIS
thymocyte selection associated
THEMIS; thymocyte selection associated; protein THEMIS; C6orf190; C6orf207; MGC163388; THMS1_HUMAN; Thymocyte expressed molecule involved in selection; Thymocyte selection pathway associated; Thymocyte-expressed molecule involved in selection; TSEPA; protein thylex; grb2-associating protein; thymus lymphocyte exclusively expressed; Gasp; thylex; BB160712; A430108D01; E430004N04Rik;
TRNAU1AP
tRNA selenocysteine 1 associated protein 1
TRNAU1AP; tRNA selenocysteine 1 associated protein 1; tRNA selenocysteine associated protein 1 , TRSPAP1; tRNA selenocysteine 1-associated protein 1; FLJ20503; SECP43; tRNA selenocysteine associated protein 1; tRNA selenocysteine-associated protein 1; tRN;
NALCN
sodium leak channel, non-selective
NALCN; sodium leak channel, non-selective; VGCNL1, voltage gated channel like 1; sodium leak channel non-selective protein; bA430M15.1; CanIon; voltage gated channel like 1; voltage gated channel-like protein 1; four repeat voltage-gated ion channel; VGC;
TESPA1
thymocyte expressed, positive selection associated 1
TESPA1;thymocyte expressed, positive selection associated 1;29109;ENSG00000135426;HSPC257;KIAA0748;12q13.2;KIAA0748;protein TESPA1;protein TESPA1;thymocyte-expressed positive selection-associated protein 1;
SELENBP1
selenium binding protein 1
SELENBP1;selenium binding protein 1;10719;ENSG00000143416;LPSB;SP56;hSBP;SBP56;1q21.3;FLJ13813;selenium-binding protein 1;selenium-binding protein 1;56 kDa selenium-binding protein;
Themis2
THEMIS2 thymocyte selection associated family member 2 [ Homo sapiens ]
thymocyte selection associated family member 2; 16839; Ensembl:ENSG00000130775; protein THEMIS2; protein ICB-1; basement membrane-induced; induced by contact to basement membrane 1 protein; thymocyte-expressed molecule involved in selection protein 2; ICB-1; C1orf38;
Patients with Digestive Diseases Gain Hope for Selective Therapies by Targeting Specific Neurotransmitter
Recently, Penn State College of Medicine researchers did some studies regarding neuroscience. They found separate nerve pathways regulate diverse organ functions along the upper gastrointestinal (GI) tract, which is different from what researchers found in past studies. The lead investigator of this...
Introduction to an Innovative Antibody Selection Method
It is reported in the Cell that researchers have developed a powerful innovative technique to find antibodies, especially therapeutic antibodies. A few years ago, the researchers developed a basic method to select antibodies thatnot only bind to a given target, but also have a desired biolog...
Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
As usual, Cleveland Clinic will pick out some groundbreaking pharmaceutics that may make big difference for healthcare industry in their late development stages. This year who will be picked by Cleveland? According to internal news, Gilead's sofosbuvir, Novartis heart drugs serelaxin as well as Phar...
Systematic Evolution of Ligands by Exponential Enrichment (SELEX)
The Systematic Evolution of Ligands by Exponential Enrichment (SELEX) is a combinatorial chemical technology developed in the 1990s. Using this technique, aptamers with high specific affinity for the target substance can be screened from a library of random single-stranded nucleic acid sequences, an...
